2005
DOI: 10.1124/jpet.105.084046
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Azumolene on Ca2+Sparks in Skeletal Muscle Fibers

Abstract: Azumolene is an analog of dantrolene, the only approved medicine for treatment of malignant hyperthermia (MH). The pharmacological mechanism of these drugs is to inhibit skeletal muscle sarcoplasmic reticulum (SR)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
22
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 40 publications
1
22
0
Order By: Relevance
“…Azumolene, a Ca 2ϩ release modulator that suppresses the activity of the SR RyR Ca 2ϩ release channel (28), was used to address its effect on the activity of Ca 2ϩ sparks on day 7 dedifferentiated fibers. In fluo 4-loaded day 7 dedifferentiated fibers azumolene treatment (10 M for 10 min) completely suppressed Ca 2ϩ release events, indicating that RyR channel activity underlies increased Ca 2ϩ sparks (data not shown).…”
Section: Resultsmentioning
confidence: 99%
“…Azumolene, a Ca 2ϩ release modulator that suppresses the activity of the SR RyR Ca 2ϩ release channel (28), was used to address its effect on the activity of Ca 2ϩ sparks on day 7 dedifferentiated fibers. In fluo 4-loaded day 7 dedifferentiated fibers azumolene treatment (10 M for 10 min) completely suppressed Ca 2ϩ release events, indicating that RyR channel activity underlies increased Ca 2ϩ sparks (data not shown).…”
Section: Resultsmentioning
confidence: 99%
“…Dantrolene was also found to inhibit DHPR Ca 2ϩ currents (4,43). In addition, azumolene (a dantrolene analog) decreased the frequency but not the shape (amplitude, duration, and width) of local events of RyR1-mediated Ca 2ϩ release (Ca 2ϩ sparks), indicating that the gating of RyR1 channels during the events was not affected by dantrolene derivatives (49). Similar decrease in Ca 2ϩ spark frequency is found with the DHPR antagonist nifedipine, which appears to stabilize physical interactions between DHPR and RyR1 (52).…”
Section: Discussionmentioning
confidence: 99%
“…Dantrolene, and presumably its more water-soluble analogue azumolene, bind with high affinity to skeletal muscle SR membrane preparations, but not to sarcolemmal or t-tubule membranes [42,43]. A discrete dantrolene binding site within RyR1 (a.a. 590-609) was identified [43] and proposed to suppress RyR1 channel opening [44] by promoting RyR1 interdomain interactions that stabilize the closed state of the channel [45]. While dantrolene reduces electrically-evoked Ca 2+ release in myotubes [46], as well as both SR Ca 2+ release and [ 3 H]ryanodine binding to SR vesicles [47], two separate studies failed to observe a direct effect of dantrolene on purified RyR1 channel gating following incorporation in artificial planar lipid bilayers [46,48].…”
Section: Discussionmentioning
confidence: 99%